| |
|
|
|
Kazia Therapeutics Limited  
|
|
3.152 -0.181 (-0.05%) |
10-18 12:46 |
|
Open: |
3.152 |
Pre close: |
3.3334 |
Target:
|
4.03 
|
|
High: |
3.152 |
Low: |
3.152 |
Resistance:
|
3.45
3.95
|
|
Volume: |
269 |
Market Cap: |
19M |
Support:
|
2.65
2.20
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.29
|
MACD |
MACD(12,26):
|
0.08 |
|
MA(20): |
3.47 |
Signal(12,26,9): |
0.15 |
|
MA(100): |
2.81 |
Stochastic Oscillator |
%K(14,3):
|
27.22 |
|
MA(250): |
2.97  |
%D(3): |
30.30 |
|
Average Volume(K) |
3-Month: |
312
|
52-Week |
High:
|
4.27 |
|
10-Days: |
281 |
Low: |
2.04 |
|
RSI |
RSI(14):
|
46.38 |
Change(%): |
7.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.920 |
Return on Equity (ttm) |
-61.4 |
Shares Out. (M) |
6.22 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-22.0 |
Shares Float (M) |
3.84 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-50.4 |
% Held by Institutions |
1.92 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.248 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
2.940 |
EBITDA (p.s.) |
0.000 |
P/E |
-3.43 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.07 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
